66 related articles for article (PubMed ID: 9507640)
1. The clinical significance of T-cell superantigens.
Michie CA; Cohen J
Trends Microbiol; 1998 Feb; 6(2):61-5. PubMed ID: 9507640
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.
Xu GL; Zhu XH; Guo B; Wu YZ
Mol Immunol; 2004 May; 41(1):1-8. PubMed ID: 15140570
[TBL] [Abstract][Full Text] [Related]
3. Superantigens.
Stow NW; Douglas R; Tantilipikorn P; Lacroix JS
Otolaryngol Clin North Am; 2010 Jun; 43(3):489-502, vii. PubMed ID: 20525505
[TBL] [Abstract][Full Text] [Related]
4. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.
Maxwell JR; Campbell JD; Kim CH; Vella AT
J Immunol; 1999 Feb; 162(4):2024-34. PubMed ID: 9973474
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
[TBL] [Abstract][Full Text] [Related]
6. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens.
Ou LS; Goleva E; Hall C; Leung DY
J Allergy Clin Immunol; 2004 Apr; 113(4):756-63. PubMed ID: 15100684
[TBL] [Abstract][Full Text] [Related]
7. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
Bendiksen S; Rekvig OP
Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
[TBL] [Abstract][Full Text] [Related]
9. T-cell tolerance induced by repeated antigen stimulation: selective loss of Foxp3- conventional CD4 T cells and induction of CD4 T-cell anergy.
Eroukhmanoff L; Oderup C; Ivars F
Eur J Immunol; 2009 Apr; 39(4):1078-87. PubMed ID: 19283777
[TBL] [Abstract][Full Text] [Related]
10. Superantigens and their role in autoimmune disorders.
Schiffenbauer J
Arch Immunol Ther Exp (Warsz); 1999; 47(1):17-24. PubMed ID: 11729824
[TBL] [Abstract][Full Text] [Related]
11. Modulation of T cell responses after cross-talk between antigen presenting cells and T cells: a give-and-take relationship.
Wauben MH; 't Hoen EN; Taams LS
Novartis Found Symp; 2003; 252():211-20; discussion 220-5, 257-67. PubMed ID: 14609221
[TBL] [Abstract][Full Text] [Related]
12. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.
Taams LS; van Eden W; Wauben MH
J Immunol; 1999 Feb; 162(4):1974-81. PubMed ID: 9973467
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of Kawasaki disease and superantigens.
Uchiyama T; Kato H
Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
[TBL] [Abstract][Full Text] [Related]
15. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
16. T-cell anergy and peripheral T-cell tolerance.
Lechler R; Chai JG; Marelli-Berg F; Lombardi G
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):625-37. PubMed ID: 11375066
[TBL] [Abstract][Full Text] [Related]
17. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
Okamoto S; Kawabata S; Nakagawa I; Hamada S
Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
19. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
20. [Superantigens].
Tomonari K
Ryumachi; 1994 Apr; 34(2):183-4. PubMed ID: 8202838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
